Days after Vancouver’s Aspect Biosystems Ltd. landed US$115 million in Series B financing in early January, CEO Tamer Mohamed likely surprised many by telling BIV that he thought the investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback